Tag: eShunt

CereVasc announces US FDA approval for second IDE study of eShunt...

CereVasc announced today that the US Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) application to initiate a pilot trial...

Pedro Lylyk

Pedro Lylyk’s work and achievements in the neurosurgical field have spanned several decades, and range from a momentous intracranial stent placement in 1996, to...

First patient treated in clinical trial of CereVasc’s eShunt system for...

CereVasc has announced treatment of the first patient in its clinical study of the eShunt system in patients with normal-pressure hydrocephalus (NPH). Following approval from Argentina's...

CereVasc receives FDA nod to study eShunt system in normal-pressure hydrocephalus...

CereVasc has announced that the US Food and Drug Administration (FDA) has approved its investigational device exemption (IDE) application to initiate a pilot trial...

CereVasc announces publication of first-in-human case report with eShunt system

CereVasc has announced the publication of a case report detailing the first treatment in a study of its eShunt system—an investigational device intended to...

eShunt system offers promise for endovascular treatment of hydrocephalus

 “I have tried several devices in the last 10 or 20 years, but I think this is absolutely different—this is the first time that...

First patient treated in eShunt clinical trial 

CereVasc has announced the treatment of the first patient in a study of its eShunt System, an investigational device intended to treat communicating hydrocephalus...